Key result
Primary PCI and modern therapies markedly reduce acute myocardial infarction mortality compared to historical rates.
Reassures clinicians of AMI survival gains with modern care; leaves open identification of residual modifiable risks in contemporary cohorts.
A little over 50 years ago, my father had a heart attack. He was driven to the hospital by friends after having “indigestion” for 2 days. He spent 2 weeks as an inpatient on an unmonitored rehabilitation ward and was treated principally with warfarin and digitalis. He was lucky and survived, but in that era, more than 20% of patients with an acute myocardial infarction died. Fast-forward to today, when public education about early recognition of symptoms, emergency transport, monitored coronary care units, and early reperfusion by means of primary percutaneous coronary intervention (PCI) have markedly reduced mortality from acute . . .
No takes yet. Share an insight, caveat, or question.
George Wayne Vetrovec (2008) conducted an editorial in Acute myocardial infarction. Modern advancements including primary percutaneous coronary intervention have markedly reduced acute myocardial infarction mortality compared to historical rates exceeding 20%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: